Stifel analysts updated their outlook on HubSpot Inc (NYSE: NYSE:HUBS), raising the stock's price target from the previous $880.00 to a new figure of $925.00. The firm continues to endorse the stock ...

在其他近期新闻中，多位分析师在卡夫亨氏发布第四季度业绩后对其进行了评估。Bernstein分析师Alexia ...

周四，Stifel分析师调整了对CRISPR Therapeutics (NASDAQ: CRSP )的展望。该公司目前股价为43.09美元，市值37亿美元。分析师将目标价从此前的53美元下调至49美元，同时维持对该公司股票的持有评级。此次调整反映了对Casgevy（该公司基因编辑疗法）市场接受度的谨慎态度。根据InvestingPro分析，基于其专有的公允价值模型，该股票目前估值合理。

We recently compiled a list of the 10 AI News and Ratings Making Waves on Wall Street. In this article, we are going to take ...

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...

Onsemi (NASDAQ:ON – Get Free Report) had its price objective reduced by research analysts at Stifel Nicolaus from $60.00 to $52.00 in a research note issued on Tuesday,Benzinga reports. The firm ...

SPS Commerce (NASDAQ:SPSC – Get Free Report) had its price target decreased by analysts at Stifel Nicolaus from $225.00 to $200.00 in a report released on Tuesday,Benzinga reports. The brokerage ...

CNW/ - Mawson Finland Limited ("Mawson" or the "Company") (TSXV: MFL) is pleased to announce that it has entered ...

MoneyLion operates a “content-as-a-service platform” called mFeed, and Stifel Discover is expected to deliver personalized ...

Stifel raised the firm’s price target on Confluent (CFLT) to $40 from $37 and keeps a Buy rating on the shares following what the firm calls “a ...

The 2025/26 season will include a concert dedicated to Chuck Berry, the return of former music directors Leonard Slatkin and ...

Elon Musk’s bid for OpenAI and his divisive political image raise new risks for Tesla’s expensive stock.